13 December 2007
GlaxoSmithKline Neurosciences Seminar 2007
Moncef Slaoui, Chairman Research and Development, along with Senior R&D representatives presented on GSK's emerging neuroscience pipeline for the treatment of diseases including Alzheimer's disease, depression, multiple sclerosis, restless legs syndrome and schizophrenia.

6 November 2007
Credit Suisse 7th Annual European Large Cap Pharmaceutical Conference
Julian Heslop, CFO, gave a presentation at the Credit Suisse 7th Annual European Large Cap Pharmaceutical Conference on 6 November in London. The presentation was attended by over institutional investors and portfolio managers. Julian' presented on the GSK business and recent third quarter results.

24 October 2007
GlaxoSmithKline 2007 Q3 Results

17 September 2007
GlaxoSmithKline Hosts Investor Roundtable Meeting in Philadelphia
Chris Viehbacher, President, US Pharmaceuticals, hosted a Roundtable Meeting on 17 September in Philadelphia. David Pernock, SVP, General Pharmaceuticals & Vaccines, Stan Hull, SVP, US Pharmaceuticals, Peter Hare, VP, HIV Business and Steve Stefano, SVP, NeuroHealth and Managed Markets gave presentations on the US pharmaceutical business. The meeting was attended by approximately 35 institutional investors and portfolio managers. Slides from the presentations are available for view.

25 July 2007
GlaxoSmithKline 2007 Q2 Results

28 June 2007
GlaxoSmithKline Cervarix interim clinical trial results 2007
Jim Tursi, Director of Medical Affairs – Cervical Cancer Vaccines (GSK) discussed the data from the Cervarix interim clinical trial results that were published in the Lancet today. This largest cervical cancer vaccine efficacy trial shows that Cervarix provides excellent protection against lesions caused by the most common cancer-causing virus types and also shows significant additional protection against infection with virus types beyond HPV 16 and 18.

19 June 2007
GlaxoSmithKline Oncology Seminar 2007
Moncef Slaoui, Chairman Research and Development along with Senior R&D Representatives presented on GSK's Oncology Pipeline and portfolio.

12 June 2007
Goldman Sachs 28th Annual Global Healthcare Conference
Chris Viehbacher, President, US Pharmaceuticals, gave a presentation at the Goldman Sachs Twenty-Eighth Annual Global Healthcare Conference on June 12 in California. The conference featured presentations by more than 130 companies from the pharmaceutical, biotechnology, medical supply and device, healthcare services, managed care, distribution and information technology sectors. Chris provided highlights from the first quarter results followed by a question and answer session.

23 May 2007
Annual General Meeting
Board Chairman Sir Christopher Gent led the company's Annual General Meeting for shareholders in London. JP Garnier presented an update on our business.

23 May 2007
Citigroup Healthcare Conference
Chris Viehbacher, President, US Pharmaceuticals, gave a presentation at the Citigroup Health Care Conference on May 23rd in New York. The presentation was attended by over 100 institutional investors and portfolio managers. Chris' presentation consisted of 15 minutes of opening remarks on the first quarter results followed by a question and answer session.

3 May 2007
Deutsche Bank Securities 32nd Annual Healthcare Conference
Julian Heslop, CFO, gave a presentation at the Deutsche Bank Securities 32nd Annual Healthcare Conference on 3 May in Washington, DC. The presentation was attended by over 100 institutional investors and portfolio managers. Julian's presentation consisted of 15 minutes of opening remarks on the first quarter results followed by 30 minutes of Q&A.

25 April 2007
GlaxoSmithKline 2007 Q1 Results

23 Mar 2007
GlaxoSmithKline Hosts Investor Roundtable Meeting in London
Chris Viehbacher, President, US Pharmaceuticals, hosted a Roundtable Meeting on 23 March in London. Stan Hull, SVP, US Pharmaceuticals, David Pernock, SVP, General Pharmaceuticals Business Unit, James Tursi, Director of Medical Affairs Cervical Cancer Vaccines and Steve Stefano, SVP, NeuroHealth and Managed Markets gave presentations on the US pharmaceutical business. The meeting was attended by approximately 50 institutional investors and portfolio managers. Slides from the presentations are available for view.

19 Mar 2007
Lehman Brothers Health Care Conference
David Stout, President, Pharmaceutical Operations, gave a presentation at the Lehman Brothers Health Care Conference on Monday, March 19, 2007 in Miami. David discussed GSK's 2006 results and provided an overview of the key growth drivers. More than 100 institutional investors and portfolio managers attended the presentation.

12 Mar 2007
SG Cowen Health Care Conference
David Stout, President, Pharmaceutical Operations, gave a presentation at the SG Cowen Health Care Conference on March 12, 2007 in Boston. The presentation was attended by over 100 institutional investors and portfolio managers. David provided an overview of GSK's 2006 results and key growth drivers.

08 Feb 2007
GlaxoSmithKline 2006 Annual Results

04 Jan 2007
Morgan Stanley Pharmaceuticals CEOs Unplugged Conference
David Stout, President, Pharmaceuticals Operations, gave the lunchtime presentation at the Morgan Stanley Pharmaceuticals CEOs Unplugged Conference on 4 January in New York.